PCNA and cancer: In particular, the discovery of the cancer-associated isoform of PCNA (caPCNA) [7] and the development of small molecule and peptide agents that specifically target caPCNA allows for the selective targeting of cancer cells without causing significant toxicity to normal cells or experimental animals [8,9].